Zeyuan Lin

594 total citations
15 papers, 438 citations indexed

About

Zeyuan Lin is a scholar working on Molecular Biology, Clinical Biochemistry and Nephrology. According to data from OpenAlex, Zeyuan Lin has authored 15 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 2 papers in Nephrology. Recurrent topics in Zeyuan Lin's work include Connexins and lens biology (6 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Advanced Glycation End Products research (5 papers). Zeyuan Lin is often cited by papers focused on Connexins and lens biology (6 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Advanced Glycation End Products research (5 papers). Zeyuan Lin collaborates with scholars based in China. Zeyuan Lin's co-authors include Yan Yang, Haiming Xiao, Heqing Huang, Meng Zhang, Peiqing Liu, Zhanchi Xu, Xiaohong Sun, Shijian Quan, Zhongqiu Liu and Zhiquan Chen and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Zeyuan Lin

15 papers receiving 438 citations

Peers

Zeyuan Lin
Zhimin Mao China
Anmei Shu China
Yan‐Zi Yang China
Bu-Hui Liu China
Xisheng Xie China
Yangyang Wang China
Santosh Kumar Goru India
Jiarong Gao China
Yanru Huang China
Brijesh Sutariya India
Zhimin Mao China
Zeyuan Lin
Citations per year, relative to Zeyuan Lin Zeyuan Lin (= 1×) peers Zhimin Mao

Countries citing papers authored by Zeyuan Lin

Since Specialization
Citations

This map shows the geographic impact of Zeyuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyuan Lin more than expected).

Fields of papers citing papers by Zeyuan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyuan Lin. The network helps show where Zeyuan Lin may publish in the future.

Co-authorship network of co-authors of Zeyuan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyuan Lin. A scholar is included among the top collaborators of Zeyuan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyuan Lin. Zeyuan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Shanshan, Haiming Xiao, Xiaohong Sun, et al.. (2023). Connexin32 Promotes the Activation of Foxo3a to Ameliorate Diabetic Nephropathy via Inhibiting the Polyubiquitination and Degradation of Sirt1. Antioxidants and Redox Signaling. 39(4-6). 241–261. 5 indexed citations
2.
Lin, Zeyuan, Shanshan Li, Haiming Xiao, et al.. (2023). The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy. Cell Reports. 42(8). 112851–112851. 9 indexed citations
3.
Yang, Yan, Haiming Xiao, Zeyuan Lin, et al.. (2022). The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article). Biochemical Pharmacology. 206. 115339–115339. 11 indexed citations
4.
Sun, Xiaohong, Haiming Xiao, Rui Chen, et al.. (2022). Connexin32 ameliorates epithelial-to-mesenchymal-transition in diabetic renal tubular via inhibiting NOX4. Pharmacological Research. 176. 106084–106084. 6 indexed citations
5.
Chen, Rui, Haiming Xiao, Shanshan Li, et al.. (2022). Fraxin Promotes the Activation of Nrf2/ARE Pathway via Increasing the Expression of Connexin43 to Ameliorate Diabetic Renal Fibrosis. Frontiers in Pharmacology. 13. 853383–853383. 11 indexed citations
6.
Xu, Zhanchi, Meng Zhang, Yu Wang, et al.. (2022). Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway. Frontiers in Pharmacology. 13. 848915–848915. 21 indexed citations
7.
Li, Shanshan, Zeyuan Lin, Haiming Xiao, et al.. (2022). Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism. 139. 155378–155378. 31 indexed citations
8.
Xiao, Haiming, Xiao-Hong Sun, Zeyuan Lin, et al.. (2022). Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Acta Pharmaceutica Sinica B. 12(6). 2887–2904. 111 indexed citations
9.
Sun, Xiaohong, Haiming Xiao, Meng Zhang, et al.. (2021). USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells. Biochemical Pharmacology. 188. 114562–114562. 23 indexed citations
10.
Yang, Yan, Jie Li, Lingqiang Zhang, et al.. (2020). CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes. Pharmacological Research. 163. 105333–105333. 11 indexed citations
11.
Li, Xuejuan, Zhanchi Xu, Yan Yang, et al.. (2020). Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacologica Sinica. 41(12). 1587–1596. 37 indexed citations
12.
Sun, Xiaohong, Kaipeng Huang, Zeyuan Lin, et al.. (2020). Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway. Clinical Science. 134(13). 1573–1592. 35 indexed citations
13.
Chen, Zhiquan, Xiaohong Sun, Qiuhong Chen, et al.. (2019). Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48‐linked NADPH oxidase 4 polyubiquitination and degradation. British Journal of Pharmacology. 177(1). 145–160. 24 indexed citations
14.
Xiao, Haiming, Xiaohong Sun, Renbin Liu, et al.. (2019). Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. Pharmacological Research. 151. 104559–104559. 85 indexed citations
15.
Sun, Xiaohong, Haiming Xiao, Yan Yang, et al.. (2019). PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway. Experimental Cell Research. 381(2). 301–310. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhimin Mao Breakdown of academic impact, for papers by Anmei Shu Breakdown of academic impact, for papers by Yan‐Zi Yang Breakdown of academic impact, for papers by Bu-Hui Liu Breakdown of academic impact, for papers by Xisheng Xie Breakdown of academic impact, for papers by Yangyang Wang Breakdown of academic impact, for papers by Santosh Kumar Goru Breakdown of academic impact, for papers by Jiarong Gao Breakdown of academic impact, for papers by Yanru Huang Breakdown of academic impact, for papers by Brijesh Sutariya
Rankless by CCL
2026